Skip to main content

Initiation of Genomic Instability, Cellular Senescence, and Organismal Aging by Dysfunctional Telomeres

  • Chapter
Telomeres and Telomerase in Ageing, Disease, and Cancer
  • 1331 Accesses

Telomeres are ribonucleoprotein structures that protect the end of linear chromosomes from recognition as DNA double-stranded breaks and activation of a DNA damage response. Telomere-associated proteins also regulate telomerase, the protein responsible for maintaining telomere length. Loss of telomere function results from either alteration in the telosome/shelterin complex that exerts capping function at telomeres, or from progressive loss of telomeric repeats necessary to maintain proper telomeric structure. Dysfunctional telomeres activate p53 to initiate cell cycle arrest/ cellular senescence and may play an important role in aging. Here I describe the use of mouse models to probe the impact of dysfunctional telomeres upon organismal aging.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB (1992) Telomere length predicts replicative capacity of human fibroblasts. Proc Natal Aced Sci U S A 89: 10114–18.

    Article  CAS  Google Scholar 

  • Artandi S, Chang S, Lee S, Alson, S, Gottlieb G, Chin L, and Depinho RA (2000) Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406: 641–45.

    Article  PubMed  CAS  Google Scholar 

  • Artandi S, Alson S, Tietze M, Sharpless N, Ye S, Greenberg RA, Castrillon DH, Horner JW, Weiler S, Carrasco R, DePinho, RA (2002) Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci U S A 99: 8191–94.

    Article  PubMed  CAS  Google Scholar 

  • Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864–70.

    Article  PubMed  CAS  Google Scholar 

  • Baumann P, Cech TR (2001) Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 292: 1171–75.

    Article  PubMed  CAS  Google Scholar 

  • Blackburn EH (2001) Switching and signaling at the telomere. Cell 106: 661–73.

    Article  PubMed  CAS  Google Scholar 

  • Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA., Greider CW (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25–34.

    Article  PubMed  CAS  Google Scholar 

  • Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE (1998) Extension of life-span by introduction of telomerase into normal human cells [see comments]. Science 279: 349–52.

    Article  PubMed  CAS  Google Scholar 

  • Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ; West of Scotland Coronary Prevention Study Group (2007) Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 369: 107–14.

    Google Scholar 

  • Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR (1997) Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271–74.

    Article  PubMed  CAS  Google Scholar 

  • Campisi J (1997) The biology of replicative senescence. Eur J Cancer 33: 703–09.

    Article  PubMed  CAS  Google Scholar 

  • Campisi J (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120: 513–22.

    Article  PubMed  CAS  Google Scholar 

  • Cao L, Li W, Kim S, Brodie SG, Deng CX (2003) Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev 17: 201–13.

    Google Scholar 

  • Cawthon RM, Smith KR, O’Brien E, Sivatchenko A, Kerber RA (2003) Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361: 393–95.

    Article  PubMed  CAS  Google Scholar 

  • Chang S, Khoo C, DePinho RA (2001) Modeling chromosomal instability and epithelial carcinogenesis in the telomerase deficient mouse. Sem Oncol 11: 227–38.

    CAS  Google Scholar 

  • Chang S, Khoo C, Naylor M, Maser R, DePinho RA (2003) Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev 17: 88–100.

    Article  PubMed  CAS  Google Scholar 

  • Chang S, Multani A S, Cabrera NG, Naylor MI, Laud P, Lombard, D, Pathak S, Guarente L, DePinho RA (2004) Essential role of limiting telomeres in the [athogenesis of Werner Syndrome. Nature Gen 36: 877–82.

    Article  CAS  Google Scholar 

  • Chin L, Artandi S, ShenQ, Tam A, Lee S, Gottlieb G, Greider CW, DePinho RA (1999) p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97: 527–38.

    Article  PubMed  CAS  Google Scholar 

  • Choudhury AR, Ju Z, Djojosubroto MW, Schienke A, Lechel A, Schaetzlein S, Jiang H, Stepczynska A, Wang C, Buer J, Lee HW, von Zglinicki T, Ganser A, Schirmacher P, Nakauchi H, Rudolph KL (2007) Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet 39: 99–105.

    Article  PubMed  CAS  Google Scholar 

  • Christophorou MA, Martin-Zanca D, Soucek L, Lawlor ER, Brown-Swigart L, Verschuren EW, Evan GI (2006) The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443: 214–17.

    Article  PubMed  CAS  Google Scholar 

  • Cosme-Blanco W, Shen W, Lazar A, Pathak S, Lozano G, Multani AS, and Chang S (2007) Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by activating p53-mediated cellular senescence. EMBO Reports, in press.

    Google Scholar 

  • Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921–29.

    PubMed  CAS  Google Scholar 

  • Counter CM, Meyerson M, Eaton EN, Weinberg RA (1997) The catalytic subunit of yeast telomerase. Proc Natl Acad Sci USA 94: 9202–07.

    Article  PubMed  CAS  Google Scholar 

  • d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194–98.

    Article  PubMed  CAS  Google Scholar 

  • de Boer J, Andressoo JO, de Wit J, Huijmans J, Beems RB, van Steeg H, Weeda G, van der Horst GT, van Leeuwen W, Themmen AP, Meradji M, Hoeijmakers JH (2002) Premature aging in mice deficient in DNA repair and transcription. Science 296: 1276–79.

    Article  PubMed  Google Scholar 

  • de Lange, T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100–10.

    Article  PubMed  CAS  Google Scholar 

  • Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363–67.

    Google Scholar 

  • Dokal I (2001) Dyskeratosis congenita. A disease of premature ageing. Lancet 358 Suppl, S27.

    Google Scholar 

  • Dolle ME, Giese H, Hopkins CL, Martus HJ, Hausdorff JM, Vijg J (1997) Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nat Genet 17: 431–34.

    Article  PubMed  CAS  Google Scholar 

  • Du X, Shen J, Kugan N, Furth E, Lombard D, Cheung C, Pak S, Luo G, Pignolo R, DePinho RA, Guarente L, Johnson FB (2004) Telomere shortening exposes functions for the Werner and Bloom syndrome genes in mice. Mol Cell Biol. 19: 8437–46.

    Article  CAS  Google Scholar 

  • Faragher RG, Kill IR, Hunter JA, Pope FM, Tannock C, Shall S (1993) The gene responsible for Werner syndrome may be a cell division “counting” gene. Proc Natl Acad Sci U S A 90: 12030–34.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez-Suarez E, Samper E, Flores JM, Blasco, MA (2000) Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 26: 114–17.

    Article  PubMed  CAS  Google Scholar 

  • Goytisolo FA, Samper E, Martin-Caballero J, Finnon P, Herrera E, Flores JM, Bouffler SD, Blasco MA (2000) Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals. J Exp Med. 192: 1625–36.

    Article  PubMed  CAS  Google Scholar 

  • Goytisolo FA Blasco MA (2002) Many ways to telomere dysfunction: in vitro studies using mouse models. Oncogene 21: 584–91.

    Article  PubMed  CAS  Google Scholar 

  • Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho RA (1998) Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16: 1723–30.

    Article  PubMed  CAS  Google Scholar 

  • Greenberg RA, Chin L, Femino A, Lee KH, Gottlieb GJ, Singer RH, Greider CW and DePinho, RA (1999) Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97: 515–25.

    Article  PubMed  CAS  Google Scholar 

  • Greider CW (1996) Telomere length regulation. Annu Rev Biochem 65: 337–65.

    Article  PubMed  CAS  Google Scholar 

  • Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H, and de Lange T (1999) Mammalian telomeres end in a large duplex loop. Cell 97: 503–14.

    Article  PubMed  CAS  Google Scholar 

  • Hackett JA, Feldser DM, Greider CW (2001) Telomere dysfunction increases mutation rate and genomic instability. Cell 106: 275–86.

    Article  PubMed  CAS  Google Scholar 

  • Hande, MP, Samper, E, Lansdorp, P Blasco MA (1999) Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol 144: 589–601.

    Article  PubMed  CAS  Google Scholar 

  • Hara E, Tsurui, H, Shinozaki, A, Nakada, S Oda, S (1991) Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem Biophys Res Commun 179: 528–34.

    Google Scholar 

  • Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345: 458–60.

    Article  PubMed  CAS  Google Scholar 

  • Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, BacchettiS, Hirte HW, Counter CM, Greider CW (1994). Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol 59: 307–15.

    PubMed  CAS  Google Scholar 

  • Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, Mar V, Bass MB, and Robinson MO (1997) Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 11: 3109–15.

    Article  PubMed  CAS  Google Scholar 

  • Hayflick L (1961) The serial cultivation of human diploid cell strains. Exp. Cell Res. 25: 585–621.

    Article  Google Scholar 

  • Hemann MT, Strong, MA, Hao, LY, Greider, CW (2001) The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107: 67–77.

    Article  PubMed  CAS  Google Scholar 

  • Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM (2006) Cellular senescence in aging primates. Science 311: 1257.

    Article  PubMed  CAS  Google Scholar 

  • Herrera E, Martinez AC, Blasco MA (2000) Impaired germinal center reaction in mice with short telomeres. EMBO J 19: 472–81.

    Article  PubMed  CAS  Google Scholar 

  • Itahana K, Dimri G, Campisi J (2001) Regulation of cellular senescence by p53. Eur J Biochem 268: 2784–91.

    Article  PubMed  CAS  Google Scholar 

  • Kelleher C, Kurth I, Lingner J (2005) Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol Cell Biol. 25: 808–18.

    Article  PubMed  CAS  Google Scholar 

  • Kipling D, Cooke HJ (1990) Hypervariable ultra-long telomeres in mice. Nature 347: 400–02.

    Article  PubMed  CAS  Google Scholar 

  • Krtolica A, Campisi J (2002) Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 34: 1401–14.

    Article  PubMed  CAS  Google Scholar 

  • Laud PR, Multani AS, Bailey SM, Wu L, Ma J, Kingsley C, Lebel M, Pathak S, DePinho RA, Chang S (2005) Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway. Genes Dev 19: 2560–70.

    Article  PubMed  CAS  Google Scholar 

  • Lee HW, Blasco MA, Gottlieb GJ, Horner JW, Greider CW, DePinho R A (1998) Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569–74.

    Article  PubMed  CAS  Google Scholar 

  • Lei M, Zaug AJ, Podell ER, Cech TR (2005) Switching human telomerase on and off with hPOT1 protein in vitro. J Biol Chem. 280: 20449–56.

    Article  PubMed  CAS  Google Scholar 

  • Liu D, O’Connor MS, Qin J, Songyang Z (2004) Telosome, a mammalian telomere-associated complex formed by multiple telomeric proteins. J Biol Chem. 279: 51338–42.

    Article  PubMed  CAS  Google Scholar 

  • Lombard DB, Beard C, Johnson B, Marciniak RA, Dausman J, Bronson R, Buhlmann JE, Lipman R, Curry R, Sharpe A, Jaenisch R, Guarente L (2000) Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 9: 3286–91.

    Article  Google Scholar 

  • Loayza D, de Lange (2003) POT1 as a terminal transducer of TRF1 telomere length control. Nature 423: 1013–18.

    Article  PubMed  CAS  Google Scholar 

  • Lundblad V, Blackburn EH (1993) An alternative pathway for yeast telomere maintenance rescues est1- senescence. Cell 73: 347–60.

    Article  PubMed  CAS  Google Scholar 

  • Martin GM, Sprague CA, Epstein CJ (1970) Replicative life-span of cultivated human cells. Effects of donor’s age, tissue, and genotype. Lab Invest 23: 86–92.

    PubMed  CAS  Google Scholar 

  • Martin-Rivera L, Herrera E, Albar JP, Blasco MA (1998) Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc Natl Acad Sci USA 95: 10471–76.

    Article  PubMed  CAS  Google Scholar 

  • Maser RS, DePinho RA (2002) Connecting chromosomes, crisis, and cancer. Science 297: 565–69.

    Article  PubMed  CAS  Google Scholar 

  • McClintock B (1941) The stability of broken ends of chromosomes in Zea mays. Genetics 26: 234–82.

    PubMed  CAS  Google Scholar 

  • McEachern MJ, Blackburn EH (1996) Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev 10: 1822–34.

    Article  PubMed  CAS  Google Scholar 

  • Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA (1997) hEST2, the putative human telomerase catalytic subunit gene, is up- regulated in tumor cells and during immortalization. Cell 90: 785–95.

    Article  PubMed  CAS  Google Scholar 

  • Mitchell JR, Cheng J, Collins K (1999) A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3o end. Mol Cell Biol 19: 567–76.

    PubMed  CAS  Google Scholar 

  • Muller HJ (1938) The remaking of chromosomes. Collecting net 8: 182–95.

    Google Scholar 

  • Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955–59.

    Article  PubMed  CAS  Google Scholar 

  • Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F (1997) TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 88: 875–84.

    Article  PubMed  CAS  Google Scholar 

  • Newbold RF (1997) Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba Found Symp 211: 177–89.

    PubMed  CAS  Google Scholar 

  • O’Hagan R, Chang S, Maser R, Mohan R, Artandi S, Chin L, DePinho RA (2002) Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2: 149–57.

    Article  PubMed  Google Scholar 

  • Prowse KR, Avilion AA, Greider CW (1993) Identification of a nonprocessive telomerase activity from mouse cells. Proc Natl Acad Sci U S A 90: 1493–97.

    Article  PubMed  CAS  Google Scholar 

  • Prowse KR, Greider CW (1995) Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 92: 4818–22.

    Article  PubMed  CAS  Google Scholar 

  • Qi L, Strong MA, Karim BO, Armanios M, Huso DL, Greider CW (2003) Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis. Cancer Res. 63: 8188–96.

    Google Scholar 

  • Rohme D (1981) Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci U S A 78: 5009–13.

    Google Scholar 

  • Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C, DePinho RA (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96: 701–12.

    Article  PubMed  CAS  Google Scholar 

  • Samper E, Flores JM, Blasco MA (2001) Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc−/− mice with short telomeres. EMBO Rep 23: 23–30.

    Google Scholar 

  • Schmitt CA (2003) Senescence, apoptosis and therapy–cutting the lifelines of cancer Nat Rev Cancer 3: 286–95.

    Google Scholar 

  • Sedivy JM (1998) Can ends justify the means: telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells. Proc Natl Acad Sci U S A 95: 9078–81.

    Article  PubMed  CAS  Google Scholar 

  • Shay JW, Pereira-Smith OM, Wright WE (1991) A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196: 33–39.

    Article  PubMed  CAS  Google Scholar 

  • Shay JW, Van Der Haegen BA, Ying Y, Wright, WE (1993) The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp Cell Res 209: 45–52.

    Article  PubMed  CAS  Google Scholar 

  • Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3: 155–68.

    Article  PubMed  CAS  Google Scholar 

  • Singer MS, Gottschling DE (1994) TLC1: template RNA component of Saccharomyces cerevisiae telomerase. Science 266: 404–09.

    Article  PubMed  CAS  Google Scholar 

  • Szekely AM, Bleichert F, Numann A, Van Komen S, Manasanch E, Ben Nasr A, Canaan A, Weissman SM (2005) Werner protein protects nonproliferating cells from oxidative DNA damage. Mol Cell Biol. 25: 10492–506.

    Article  PubMed  CAS  Google Scholar 

  • Tyner SD. et al. (2002) p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45–53.

    Google Scholar 

  • Vasile E, Tomita Y, Brown LF, Kocher O, Dvorak HF (2001) Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J 15: 458–66.

    Article  PubMed  CAS  Google Scholar 

  • Vaziri H, Benchimol S (1998) Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 8: 279–82.

    Article  PubMed  CAS  Google Scholar 

  • Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, Mason PJ, Dokal I (2001) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413: 432–35.

    Article  PubMed  CAS  Google Scholar 

  • Vulliamy T, Marrone A, Szydlo R, Walne A, Mason PJ, Dokal I (2004) Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat Genet 36: 447–49.

    Article  PubMed  CAS  Google Scholar 

  • Wang F, Podell ER, Zaug AJ, Yang Y, Baciu P, Cech TR, Lei M (2007) The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature 445: 506–10.

    Article  PubMed  CAS  Google Scholar 

  • Weng NP, Granger L, Hodes RJ (1997) Telomere lengthening and telomerase activation during human B cell differentiation. Proc Natl Acad Sci U S A 94: 10827–32.

    Article  PubMed  CAS  Google Scholar 

  • Wong K, Chang S, Weiler SR, Ganesan S, Chaudhuri J, Zhu C, Artandi SE, Rudolph KL, Gottlieb GJ, Chin L, Alt FW, DePinho RA (2000) Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat Genet 26: 85–88.

    Article  PubMed  CAS  Google Scholar 

  • Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, Gu Y, Alt FW, DePinho RA (2003) Telomere dysfunction and ATM deficiency compromises organ homeostasis and accelerates ageing. Nature 421: 643–48.

    Article  PubMed  CAS  Google Scholar 

  • Wright WE, Shay JW (1992) The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 27: 383–89.

    Article  PubMed  CAS  Google Scholar 

  • Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW (1996) Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173–79.

    Article  PubMed  CAS  Google Scholar 

  • Wu L, Multani AS, He H, Cosme-Blanco W, Deng Y, Deng JM, Bachilo O, Pathak S, Tahara H, Bailey SM, Deng Y, Behringer RR, Chang S (2006) Pot1a deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126: 49–62.

    Article  PubMed  CAS  Google Scholar 

  • Xin H, Liu D, Wan M, Safari A, Kim H, Sun W, O’Connor MS, Songyang Z. (2007) TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase. Nature 445: 559–62.

    Article  PubMed  CAS  Google Scholar 

  • Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445: 656–60.

    Article  PubMed  CAS  Google Scholar 

  • Yu GL, Bradley JD, Attardi LD, Blackburn EH (1990) In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature 344: 126–32.

    Article  PubMed  CAS  Google Scholar 

  • Zijlmans JM, Martens UM, Poon SS, Raap AK, Tanke HJ, Ward RK, Lansdorp PM (1997) Telomeres in the mouse have large inter-chromosomal variations in the number of T2AG3 repeats. Proc Natl Acad Sci USA 94: 7423–28.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Chang, S. (2008). Initiation of Genomic Instability, Cellular Senescence, and Organismal Aging by Dysfunctional Telomeres. In: Rudolph, K.L. (eds) Telomeres and Telomerase in Ageing, Disease, and Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-73709-4_4

Download citation

Publish with us

Policies and ethics